02.05.2019 • NewsDede Willamsmcdermott

McDermott Wins new Kuwait Project

McDermott Wins new Kuwait Project (c) RonFullHD
McDermott Wins new Kuwait Project (c) RonFullHD

Engineering contractor McDermott International has been tapped by Kuwait Integrated Petroleum Industries Company (KIPIC) to provide basic engineering, technology and catalyst for an integrated Low Pressure Recovery (LPR) and Olefins Conversion Technology (OCT) unit as part of KIPIC's Petrochemical Refinery Integration Project (PRIZe) in Al Zour, Kuwait.

When the project is complete, the subsidiary of state-owned Kuwait Petroleum Corporation (KPC) will have capacity to produce 330,000 t/y of polymer grade propylene using refinery by-product streams. PRIZe will also add to the existing refinery a gasoline block, an aromatics block, an OCT unit and associated utility and offsite facilities.

McDermott said the new units will be closely integrated with the ZOR Refinery and LNGI projects.

The US contractor’s Lummus Technology arm is a major licensor for proprietary petrochemicals, refining, gasification and gas processing technologies, as well as a supplier of proprietary catalysts and related engineering technology. The company claims 3,100 patents and patent applications.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.